InsidersTradesSigma
Explore the full record of transactions filed by Cross John Harry III, Chief Financial Officer. Insider active across 1 companies, notably Sonnet BioTherapeutics Holdings, Inc.. In total, 1 filings have been published. Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
John Harry III Cross is the Chief Financial Officer at Sonnet BioTherapeutics Holdings, Inc. He is responsible for the financial management of the company, including financial planning and performance analysis. His role is crucial for the financial health of the organization.